IMMATICS BIOTECHNOLOGIES GMBH
IMTXW -0.31
EPS (as of 2023-12-31)
Use left/right arrow keys to switch.Breakdowns
| Name | Value |
|---|
| Revenues | 9.8M |
| Cost of Revenue | 27.6M |
| Gross Profit | -17.8M |
| Operating Expense | 36.2M |
| Operating I/L | -26.4M |
| Other Income/Expense | 6.7M |
| Interest Income | 2.3M |
| Pretax | -19.7M |
| Income Tax Expense | -4.6M |
| Net Income/Loss | -15.1M |
immatics biotechnologies GmbH
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.
